Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

152.46 +0.05 (+0.03%)
Streaming Delayed Price Updated: 9:43 AM EDT, Jun 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2
...
29 30 31 32 33 34 35 36 37
...
99 100 Next >
Russell 2000 Index Best And Worst Performing Stocks Of 2024
The Russell 2000 index continued to underperform the Dow Jones and Nasdaq 100 indices in the first quarter of 2024. 
Via Talk Markets
Topics Stocks
Why 3M Stock Was Moving Higher Today
Investors applauded the spin-off of its healthcare business. 
Via The Motley Fool
Looking Into Johnson & Johnson's Recent Short Interest
Via Benzinga
2024 S&P 500 Bull Market: 2 Unstoppable Growth Stocks to Buy Right Now
The fresh bull market is attracting investors of all trading styles. 
Via The Motley Fool
Topics Stocks
3 Reliable Dividend Growth Stocks With Yields Above 3% That You Can Buy Now and Hold for at Least a Decade
These advantaged businesses have what it takes to keep raising their payouts. 
Via The Motley Fool
Assessing Johnson &amp; Johnson's Performance Against Competitors In Pharmaceuticals Industry
Via Benzinga
Why Shockwave Medical Stock Rallied as Much as 18% Higher This Week
Buyout rumors and love from Wall Street propelled the stock to double-digit gains. 
Via The Motley Fool
3 Value Stocks to Buy on the Dip: March 2024
With money rotating away from risk-on enterprises, investors ought to pivot and consider value stocks to buy. 
Via InvestorPlace
Johnson & Johnson Has An Opportunity In Talc-Cancer Lawsuit, Can Challenge Scientific Evidence In Federal Ruling
Johnson & Johnson faces legal scrutiny over talc-cancer link. Recent rulings could impact 53,000+ lawsuits. Learn more about the $700 million settlement and evolving evidence in this ongoing... 
Via Benzinga
Topics Lawsuit
3 Dividend Stocks That Are Likely to Raise Their Payouts in April
Dividend increases should soon be coming from these stocks, but be careful -- it doesn't mean all of them are great buys. 
Via The Motley Fool
Johnson & Johnson Strong Strategic Fit For Shockwave Medical, But Medtronic, Boston Scientific Could Be Other Bidder, Says Analyst
Johnson & Johnson reportedly in talks to acquire Shockwave Medical. Potential acquisition aligns with J&J's interest in expanding into cardiovascular devices. Piper Sandler considers J&J a potential... 
Via Benzinga
Shockwave Medical Stock Sees Relative Strength Rating Ride Higher
On Wednesday, Shockwave Medical stock got a positive adjustment to its Relative Strength (RS) Rating, from 90 to 94. 
Via Investor's Business Daily
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... 
Via Benzinga
7 Dow Stocks to Buy on the Dip: March 2024
Analysts expect that the market may be heading toward a correction. These are seven of the best Dow stocks to buy when prices pull back. 
Via InvestorPlace
Topics Stocks
What's Going On With Shockwave Medical Stock?
Shockwave Medical shares are trading higher Tuesday following a report suggesting Johnson & Johnson is in talks to acquire the company. According to a report from the Wall Street Journal, people... 
Via Benzinga
7 Dividend Aristocrats That Can Safeguard Your Income Through Any Crisis
With the smart money choosing to diversify its exposure to the market, now’s a good time to consider dividend aristocrat stocks. 
Via InvestorPlace
Elliott Wave Technical Analysis: Johnson & Johnson - Tuesday, March 26
The analysis reveals a trending function characterized by impulsive mode and motive structure, positioned in Wave (3). 
Via Talk Markets
Nvidia's AI Revolution Is Transforming Healthcare with Johnson & Johnson and GE Healthcare Partnerships
Nvidia announces partnerships with J&J and GE Healthcare to integrate generative AI into surgery and medical imaging at GTC AI conference. Analysts see potential for revenue growth outside tech sector.... 
Via Benzinga
Topics Artificial Intelligence
Hot Stocks: The 3 Best Opportunities for Investing in the S&P 500
Invest in these three top S&P 500 stocks to buy offering healthy upside as the Fed signals triple rate cut later this year. 
Via InvestorPlace
Topics Economy Stocks
Dividend Stock Watch List: April 2024 Edition
The stock market has continued to edge up, setting new all-time highs for what feels like every other day at this point. Therefore, it may be difficult to find undervalued dividend stocks right now.... 
Via Talk Markets
Nvidia's AI Tech Part of Novo Nordisk's New Supercomputer
Novo Nordisk and Nvidia have teamed up to develop supercomputers, aiming to accelerate drug discovery development using advanced AI technologies. 
Via MarketBeat
Topics Artificial Intelligence
7 Dividend Darlings to Scoop Up Every Time the Market Dips
These dividend stocks are some of the best in the industry and they are worth loading up on every single market dip. 
Via InvestorPlace
3M Stock Alert: 7 Things to Know About the Upcoming 3M Healthcare Spinoff
Investors are split over the upcoming launch of 3M's healthcare spinoff, Solventum. What does the spinoff mean for 3M stock? 
Via InvestorPlace
Want Decades of Passive Income? 2 Stocks to Buy Now.
There aren't many guarantees in the equity market, but the dividend payouts of Johnson & Johnson and Abbott Laboratories may be as close as it gets to a sure thing. 
Via The Motley Fool
Wall Street’s Favorite Long-Term Stocks? 3 Names That Could Make You Filthy Rich
Wall Street's favorite long-term stocks JNJ, KO, and CAT offer a blend of dividend reliability, sector diversity, and strong market presence 
Via InvestorPlace
Johnson & Johnson's Abiomed Unit Recalls Instructions For Some Impella Blood Pumps Due To Cutting Risks
Johnson & Johnson's Abiomed's Impella Left Sided Blood Pumps, used in high-risk heart procedures, recalled due to potential perforation risk. FDA reports 129 serious injuries, 49 deaths. Learn more... 
Via Benzinga
Topics Death Product Recall
Dear 3M Stock Fans, Mark Your Calendars for April 1
Investors are split on MMM stock ahead of 3M's long-awaited healthcare spinoff, Solventum, launching April 1. 
Via InvestorPlace
Why Is European Pharma Giant Argenx Valued At Over $20B Trading Higher On Thursday?
Argenx shares rise on Chugai's gMG trial disappointment. FDA-approved Vyvgart for anti-acetylcholine receptor antibody-positive adult patients. Enspryng's Phase 3 study results disappoint. Vyvgart... 
Via Benzinga
Should You Buy 3M Before April 1?
A looming stock spinoff should give investors a reason to pause. 
Via The Motley Fool
GenScript Losses Shrink On Strong Growth For Cancer Cell Therapy
Key Takeaways: GenScript’s cell therapy revenue grew by 143.7% last year as a CAR-T cell therapy developed by its Legend Biotech subsidiary gained traction Legend’s Carvykti is expected to hit annual... 
Via Benzinga
< Previous 1 2
...
29 30 31 32 33 34 35 36 37
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.